“Ethis Healthtech’s depth of experience will help bring EXCELSIOR™ to the ophthalmic investigators, industry partners and contract research organizations dedicated to the development of new therapeutics."
New York, NY (PRWEB) October 10, 2013
Ethis Healthtech, LLC, a strategic communications and business development consultancy serving emerging ophthalmic and mobile healthcare companies, announced today an exclusive agreement to market the EXCELSIOR™ image management software to the global ophthalmic clinical trial community. Developed by EyeKor, LLC, EXCELSIOR™ is a first-of-its kind web application that supports concurrent review and analysis of images from multiple imaging modalities, enhancing efficiency and accuracy in the collection and interpretation of data from ophthalmic clinical trials.
“EXCELSIOR™ is the most streamlined and comprehensive software available to help ensure the successful analysis of ophthalmic clinical trial data. It is made even more powerful by EyeKor’s unique relationships with nationally recognized reading centers and key clinicians, which harness the expertise of top image graders around the country,” says Christopher J. Murphy, DVM, PhD, and CEO, EyeKor. He continues: “Ethis Healthtech’s depth of experience in eyecare and its global clinician network will help bring EXCELSIOR™ to the ophthalmic investigators, industry partners, and contract research organizations dedicated to the development of new therapeutics for patients with ocular disease.”
EXCELSIOR™ image management software has received FDA 510k clearance as a class 2 medical device, with indications for use specifically for managing ophthalmic clinical trial data. EXCELSIOR™ provides investigators, clinical trial sponsors, and data managers secure, real-time access to their data and lets them follow its progress through each workflow stage—collection, quality analysis, grading, and interpretation—through a browser interface. Reading Center trained staff and technicians provide certification, clinical site support, and quality analysis of images—with all analysis and grading harmonized by the EXCELSIOR™ custom viewer that features image-enhancement tools specifically configured for each of the ophthalmic modalities.
“EXCELSIOR™ is the very best image management software available for ophthalmic clinical trials. It enables corporate sponsors and venture capitalists to de-risk their substantial investments in clinical trials by offering greater insight and real-time management of data collection and analysis. We are excited to help bring this unique platform to ophthalmic investigators,” says Luca Sergio, CEO of Ethis Healthtech.
About Ethis Healthtech, LLC: Ethis Healthtech serves early-stage firms in the fields of eyecare and mobile/digital healthcare by providing strategic communications, market entry planning and support, and fundraising services. Working with both pre-revenue and later-stage firms, the Ethis Healthtech team can draw upon decades of experience in ophthalmology and optometry, technology and commercialization, construction of go-to-market strategies, management of sales teams, and implementation of all aspects of marketing and communications. With a deep network among ophthalmic and digital health multinationals, clinical key opinion leaders, and investors, Ethis Healthtech supports all aspects of its clients’ growth activities.
About EyeKor, LLC: EyeKor, LLC., provides access to a coordinated network of established reading centers and clinical trial experts that offers a complete spectrum of integrated ophthalmic clinical trial services. The EXCELSIOR™ software platform is used to harmonize processes between diverse reading centers. EyeKor experts are unified through common standard operating procedures, quality control and assurance, regulatory compliance, and computing infrastructure. The company’s expertise encompasses a diverse array of ophthalmic testing methods that include fundus photography and angiography, optical coherence tomography, fundus autofluorescence imaging, dark adaptation, automated visual field testing, specular microscopy imaging, ocular surface evaluation, and electrophysiological testing.